Keystone Rx LLC, Bensalem, PA
Is Keystone Rx LLC registered with the FDA as a 503B outsourcing facility?
No matching record found in FDA’s registered outsourcing facility list (updated Nov 6, 2026) on Nov 15, 2026, searching by name and location. FDA’s compounding inspections and actions page labels it a 503A facility.
Does Keystone Rx LLC hold a Pennsylvania pharmacy license?
State board of pharmacy records for Pennsylvania are not checked: the Department of State’s license lookup (PALS) did not respond on November 6, 2026, and when tried again on November 7, 2026 it answered with a script-driven search application, which this index does not use; its monthly discipline reports are listed only through a script-driven search page. The Delaware Division of Professional Regulation also lists nonresident license A9-0001690 for Keystone Rx, BENSALEM, PA, status Closed, as of Nov 10, 2026.
Has Keystone Rx LLC had a state board action or FDA letter?
FDA letters: record found. FDA’s compounding inspections and actions page, current as of Oct 22, 2026, lists 1 state referral letter (Mar 25, 2020) and 1 FMD-145 letter (Mar 25, 2020) for Keystone Rx LLC. State board of pharmacy records for Pennsylvania are not checked: the Department of State’s license lookup (PALS) did not respond on November 6, 2026, and when tried again on November 7, 2026 it answered with a script-driven search application, which this index does not use; its monthly discipline reports are listed only through a script-driven search page. The state referral and handoff letters above are FDA’s letters to the state, not board actions.
FDA registers 503B outsourcing facilities; state boards of pharmacy license pharmacies, including 503A compounding pharmacies, and keep their own disciplinary records. Neither FDA list says which drugs a pharmacy makes.
- Names in FDA records
- Keystone Rx LLC
- Location
- Bensalem, PA
- Type as FDA labels it
- 503A
- FDA 503B list
- No matching record found
- Form 483s on FDA’s actions page
- 1
- Warning letters on FDA’s actions page
- 0
- Latest action on that page
- Mar 25, 2020
- FDA Data Dashboard inspections
- 1 inspection: 1 VAI; 1 published Form 483
- Form 483 text on this page
- 1 Form 483, 1 observation
- State board records
- Not checked
FDA inspections and letters
FDA’s compounding inspections and actions page (current as of Oct 22, 2026) lists this pharmacy as Keystone Rx LLC, a 503A facility, with 3 dated actions.
| Document | |||
|---|---|---|---|
| Mar 25, 2020 | State referral letter | State Referral Letter Issued 03/25/2020 | FDA copy (archived) |
| Mar 25, 2020 | FMD-145 letter | FMD-145 Letter Issued 03/25/2020 | Not linked by FDA |
| Jul 12, 2019 | Form 483 | 483 Issued 07/12/2019 | FDA copy (archived) |
A Form 483 lists investigator observations, not a final FDA determination. An untitled or FMD-145 letter states FDA’s view when it was issued.
FDA inspection classifications and published Form 483s
The FDA Data Dashboard, read Nov 15, 2026, lists Keystone Rx LLC, Bensalem, PA (FEI number 3015119302), matched to this page by exact name, city and state. It lists 1 inspection: 1 VAI at that site, newest first, with FDA’s classification as worded on the dashboard. Dashboard firm profile.
| Inspection ended | Classification | Project area and product type | FEI | Inspection ID |
|---|---|---|---|---|
| Jul 12, 2019 | Voluntary Action Indicated (VAI) | Drug Quality Assurance (Drugs) | 3015119302 | 1096607 |
Form 483s FDA has published for this site
- Jul 12, 2019: Form 483 to Keystone Rx LLC, published Mar 10, 2020. fda.gov
FDA classifies each inspection when it is closed: No Action Indicated (NAI) means no objectionable conditions were found or they did not justify further action; Voluntary Action Indicated (VAI) means objectionable conditions were found but FDA is not prepared to take or recommend regulatory action; Official Action Indicated (OAI) means FDA recommended regulatory or administrative action. A classification is FDA’s, not a finding by this site. The dashboard lists inspections once FDA has classified them, from fiscal year 2009 on, so a recent inspection may not appear yet.
Form 483 observations
A Form 483 lists an FDA investigator’s observations at the end of an inspection. It is not a final FDA determination. In FDA’s words: “The FDA Form 483 does not constitute a final Agency determination of whether any condition is in violation of the FD&C Act or any of its relevant regulations.” (FDA Form 483 FAQ). The firm may have answered or corrected these points; a response is not shown here unless FDA lists one.
FDA’s published Form 483 for this site has 1 numbered observation in all. Each observation is quoted from the PDF as FDA numbered it. Names of people on the form are not shown. What a Form 483 is; all 483s in this index.
Inspection Jul 8, 2019 to Jul 12, 2019: 1 observation
- Firm on the cover
- Keystone Rx LLC, 3070 Bristol Pike, Building 2, Suite 216-b, Bensalem, PA 19020-5364
- FEI number
- 3015119302
- Establishment type on the cover
- Producer of non-sterile drug products
- FDA district office on the cover
- DISTRCT ADDRESS AND PHONE NUMBER US Customhouse Rm 900 200 Chestnut St. Philadelphia, PA 19106
- Matched to this page by
- FEI number on the cover; linked from actions page, Data Dashboard
- FDA document
- Read the full 483 (PDF on fda.gov)
Observation 1
Non-microbial contamination was observed in your production area.
Specifically, on July 9, 2019, after producing Rx <Redacted B4>, 5% Flurbiprofen/ 2% Cyclobenzaprine/ 5% Lidocaine cream, and subsequent cleaning, the following were observed:
A) Apparent dried powder residue in the front grate of the biological safety cabinet (hood). There were approximately six grate holes observed with yellow residue near the scale inside the hood, approximately three grate holes observed with white residue, and approximately another four grate holes observed with yellow residue.
B) Apparent white powder residue remained on the hood's processing surface. We observed Flurbiprofen powder spillage during weighing operations for Rx <Redacted B4>• .
C) Smeared residue remained immediately in front of the grate.
D) Yellow staining remained on scale <Redacted B4> located inside the hood. The scale is used to weigh raw materials for production.
State board of pharmacy records
State board of pharmacy records for Pennsylvania are not checked: the Department of State’s license lookup (PALS) did not respond on November 6, 2026, and when tried again on November 7, 2026 it answered with a script-driven search application, which this index does not use; its monthly discipline reports are listed only through a script-driven search page.
Nonresident licenses in other states
These boards list a nonresident license whose record names this pharmacy’s own name, city and state.
Delaware Division of Professional Regulation, file dated Nov 10, 2026 (Delaware).
| License | Type as the board gives it | Name on the board record | Location | Status |
|---|---|---|---|---|
| A9-0001690 | Non Resident Pharmacy | Keystone Rx | BENSALEM, PA | Closed |
This page restates FDA’s lists and state board of pharmacy records. A Form 483, letter or board action is not a finding by this site, and a missing record is not a finding either way. A state license is matched only on the same name, city and state. Follow each link for the original document. Report an error or add a company response.
Sources
- FDA: Compounding: Inspections, Recalls, and other Actions
- FDA Registered Outsourcing Facilities (503B)
- FDA Data Dashboard: inspection classifications and published Form 483s
- FDA: FDA Form 483 Frequently Asked Questions
- Delaware Division of Professional Regulation license file
- Delaware Division of Professional Regulation disciplinary records
Records last pulled Nov 15, 2026. Every entry links to the original public record.